$146.43
-0.39[-0.27%]
At close: Apr 25
$146.43
0[0.00%]
PreMarket: 7:50PM EDT
Johnson & Johnson
(NYSE:JNJ)Johnson & Johnson Stock (NYSE:JNJ), Analyst Ratings, Price Targets, Predictions
Johnson & Johnson has a consensus price target of $171.24, established from looking at the 93 latest analyst ratings. The last 3 analyst ratings were released from HSBC, Morgan Stanley, and RBC Capital on April 18, 2024, April 17, 2024, and April 17, 2024. With an average price target of $170.67 between HSBC, Morgan Stanley, and RBC Capital, there's an implied 16.55% upside for Johnson & Johnson from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HSBC
Morgan Stanley
RBC Capital
Cantor Fitzgerald
B of A Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Johnson & Johnson
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/18/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 16.1% | HSBC | Morten Herholdt | $169 → $170 | Upgrade | Hold → Buy | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 14.05% | Morgan Stanley | Terence Flynn | $168 → $167 | Maintains | Equal-Weight | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 19.51% | RBC Capital | Shagun Singh | $181 → $175 | Maintains | Outperform | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 46.83% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 16.1% | B of A Securities | Geoff Meacham | $180 → $170 | Maintains | Neutral | Get Alert |
| 04/15/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 46.83% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 03/13/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 46.83% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 02/28/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 23.61% | RBC Capital | Shagun Singh | → $181 | Reiterates | Outperform → Outperform | Get Alert |
| 02/20/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 46.83% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 02/06/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 46.83% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/24/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 15.41% | Morgan Stanley | Terence Flynn | $170 → $169 | Maintains | Equal-Weight | Get Alert |
| 01/24/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 46.83% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/24/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 23.61% | RBC Capital | Shagun Singh | → $181 | Reiterates | Outperform → Outperform | Get Alert |
| 01/23/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 46.83% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/09/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 46.83% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/03/2024 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 19.51% | Raymond James | Jayson Bedford | $172 → $175 | Maintains | Outperform | Get Alert |
| 12/13/2023 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 11.32% | Wells Fargo | Larry Biegelsen | $170 → $163 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/06/2023 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 23.61% | RBC Capital | Shagun Singh | $178 → $181 | Maintains | Outperform | Get Alert |
| 12/01/2023 | JNJ | Buy Now | Johnson & Johnson | $146.43 | 21.56% | RBC Capital | Shagun Singh | → $178 | Reiterates | Outperform → Outperform | Get Alert |
FAQ
What is the target price for Johnson & Johnson (JNJ)?
The latest price target for Johnson & Johnson (NYSE: JNJ) was reported by HSBC on April 18, 2024. The analyst firm set a price target for $170.00 expecting JNJ to rise to within 12 months (a possible 16.10% upside). 53 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Johnson & Johnson (JNJ)?
The latest analyst rating for Johnson & Johnson (NYSE: JNJ) was provided by HSBC, and Johnson & Johnson upgraded their buy rating.
When was the last upgrade for Johnson & Johnson (JNJ)?
The last upgrade for Johnson & Johnson happened on April 18, 2024 when HSBC raised their price target to $170. HSBC previously had a hold for Johnson & Johnson.
When was the last downgrade for Johnson & Johnson (JNJ)?
The last downgrade for Johnson & Johnson happened on December 13, 2023 when Wells Fargo changed their price target from $170 to $163 for Johnson & Johnson.
When is the next analyst rating going to be posted or updated for Johnson & Johnson (JNJ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Johnson & Johnson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Johnson & Johnson was filed on April 18, 2024 so you should expect the next rating to be made available sometime around April 18, 2025.
Is the Analyst Rating Johnson & Johnson (JNJ) correct?
While ratings are subjective and will change, the latest Johnson & Johnson (JNJ) rating was a upgraded with a price target of $169.00 to $170.00. The current price Johnson & Johnson (JNJ) is trading at is $146.43, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.